BioSante Pharma (BPAX) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts BPAX Hot Sheet
Join SI Premium – FREE
BioSante Pharma (NASDAQ: BPAX) reported Q2 EPS of ($0.16), $0.06 worse than the analyst estimate of ($0.10).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
